Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Cotinga Still Alive and Kicking
View:
Post by Cotitwo on Oct 22, 2019 11:43am

Cotinga Still Alive and Kicking

Stock was halted because the financials were filed late. Problem has been worked out and we should be trading next week
The company has a very Busy week planned
Dr Richard Ho returned from a long weekend in Ireland where he presented at a Conference and also met with John Crown head of oncology at St Vincents Hospital in Dublin to discuss the planned Triple Negative Breast Cancer trial combining Coti 2 with Erbulin a drug currently used for
TNBC ( we have to raise money for this study)
Both Alison and Dr Ho arrived in San Francisco last nite to attend a Bio Conference where they have 16 meetings set up over the next 2 days
The company has also had TWO requests from 2 Major Pharma companies requesting a package of information  on Coti 2
One of the companies has reached out to Alison and they have set up a Conference call this Friday to discuss Coti 2
Also this Friday or Monday we should find out if patient 3 in Cohort 3 has completed there first cycle and if so we move on to Cohort 4  Some of the companies shareholders have stepped forward and are raising some funds for the company
I met with Alison and John Drake and they are going to keep this company going, the reason being They believe in Coti 2 
By the way Both Alison and Dr Ho have worked the last 13 months with NO PAY
Comment by johnney on Nov 23, 2019 5:47pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities